Search results
New ‘FLiRT’ COVID Variants Could Be Driving an Uptick in Cases. Here’s How to Avoid Them
Scientific American· 6 days agoThe Centers for Disease Control and Prevention’s wastewater surveillance program currently reports...
Combined flu and Covid vaccine from Moderna shows positive trial results
PA Media: Science via Yahoo News· 19 hours ago“These findings are consistent across all tested influenza strains (H1N1, H3N2 and B/Victoria) and...
Orally Administered NV-387 Results in Ideal Flat Blood Concentration Profile for Sustained Antiviral...
The Joplin Globe· 48 minutes agoA First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
New study helps explain how elderly individuals react differently to COVID-19 than young people
Medical Xpress· 14 hours agoThe COVID-19 pandemic resulted in over 700 million infections and 7 million deaths worldwide. While age is recognized as a risk factor for severe COVID-19, the reasons for this are not yet fully understood.
Moderna Seeks FDA Approval For Updated COVID-19 Shot For Upcoming Season
Benzinga· 4 days agoOn Friday, Moderna Inc. MRNA announced that it has submitted an FDA application for review of its...
FDA expands RSV vaccine use to adults aged 50 to 59
Center for Infectious Disease Research and Policy· 12 hours agoGSK said recent studies have shown RSV causes approximately 42,000 annual hospitalizations in adults aged 50 to 59.
Positive test not needed for long COVID diagnosis, experts conclude
Los Angeles Times· 6 days agoThe report concluded that “sole reliance on a documented history of SARS-CoV-2 infection when...
Sperm study recommends quarantine after COVID-19
Cosmos· 6 days agoDetails of the new study, in the journal Andrology, revealed the virus that causes COVID-19, SARS-CoV-2, can remain inside sperm for ...
Moderna’s flu-COVID combo shot hits goal in late-stage trial
Detroit News· 20 hours agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - The Boston Globe
The Boston Globe· 22 hours agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...